Vistagen's Social Anxiety Disorder Drug Disappoints In Pivotal Late-Stage Study

Vistagen shares plunge after its Phase 3 fasedienol trial for social anxiety failed to meet the primary endpoint, despite ...

Vistagen fails in late-stage trial for social anxiety disorder therapy

Vistagen (VTGN) on Wednesday announced that a Phase 3 trial for fasedienol, an experimental therapy for social anxiety ...
MPR

Fasedienol Misses Mark in Phase 3 Social Anxiety Disorder Trial

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.
PsyPost on MSN

Scientists find the biological footprint of social anxiety may reside partially in the gut

New research published in the Journal of Affective Disorders provides evidence that the gut microbiome may play a functional ...
PharmiWeb

Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placeboFavorable safety and tolerability data were ...
Time

Stop Saying These 5 Things to People With Social Anxiety

Haupt is a health and wellness editor at TIME. Haupt is a health and wellness editor at TIME. Social anxiety can make any gathering feel daunting. Long before someone steps foot in a crowded party, ...